Publications

2022

• Vitamin A metabolism in niche cells activates retinoic acid signaling and impairs stem cell function and skeletal muscle maintenance in aging mice
  Becker F
  Dissertation 2022, Jena
  
• The role of exosomes in inter-cellular and inter-organ communication of the peripheral nervous system.
  Bischoff JP, Schulz A, Morrison H
  FEBS Lett 2022, 596(5), 655-64
  
• Extensive age-dependent loss of antibody diversity in naturally short-lived turquoise killifish.
  Bradshaw WJ, Poeschla M, Placzek A, Kean S, Valenzano DR
  Elife 2022, 11, e65117 published during change of institution
  
• Impaired formation of neutrophil extracellular traps (NETs) in patients with myelodysplastic syndrome.
  Brings C, Fröbel J, Cadeddu RP, Germing U, Haas R, Gattermann N
  BLOOD ADV 2022, 6(1), 129-37
  
• Disruption of amphetamine sensitization by alteration of dendritic thin spines in the nucleus accumbens core.
  Cai WT, Kim WY, Kwak MJ, Rim H, Lee SE, Riecken LB, Morrison H, Kim JH
  J Neurochem 2022, 161(3), 266-80
  
• Deriving life extension strategies from the intestinal microbiome of human centenarians
  Chaudhari PS
  Dissertation 2022, Jena, Germany
  
• Novel biochemical, structural, and systems insights into inflammatory signaling revealed by contextual interaction proteomics.
  Ciuffa R, Uliana F, Mannion J, Mehnert M, Tenev T, Marulli C, Satanowski A, Keller LML, Rodilla Ramírez PN, Ori A, Gstaiger M, Meier P, Aebersold R
  Proc Natl Acad Sci U S A 2022, 119(40), e2117175119
  
• Partial Reduction in BRCA1 Gene Dose Modulates DNA Replication Stress Level and Thereby Contributes to Sensitivity or Resistance.
  Classen S, Rahlf E, Jungwirth J, Albers N, Hebestreit LP, Zielinski A, Poole L, Groth M, Koch P, Liehr T, Kankel S, Cordes N, Petersen C, Rothkamm K, Pospiech** H, Borgmann** K
  Int J Mol Sci 2022, 23(21) ** co-corresponding authors
  
• p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance.
  Coronel* L, Häckes* D, Schwab* K, Riege K, Hoffmann** S, Fischer** M
  Oncogene 2022, 41(7), 1063-9 * equal contribution, ** co-corresponding authors
  
• Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
  Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schröder K, Heidel FH, Böhmer FD
  Antioxidants (Basel) 2022, 11(3)